8MW0511, a novel, long-acting granulocyte-colony stimulating factor fusion protein for the prevention of chemotherapy-induced neutropenia: final results from the phase III clinical trial

The study findings confirm that 8MW0511 is not inferior to PEG-rhG-CSF in terms of efficacy and shows comparable safety profiles. Additionally, 8MW0511 has the potential to significantly decrease the duration of chemotherapy-induced neutropenia, along with a reduction in the occurrence of FN and severe neutropenia.

Authors

Institutions

Publication Details

Journal
Breast Cancer Research
Published
2025-05-06
DOI
https://doi.org/10.1186/s13058-025-02010-z
Citations
1
Primary Topic
Neutropenia and Cancer Infections
Type
article
Field-Weighted Citation Impact
1.05

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

8MW0511, a novel, long-acting granulocyte-colony stimulating factor fusion protein for the prevention of chemotherapy-induced neutropenia: final results from the phase III clinical trial

Xiuchun Chen, Ruizhen Luo, Jingfen Wang, Baojiang Li et al.
1 citations
Breast Cancer Research
Neutropenia and Cancer Infections
1.05
article

8MW0511, a novel, long-acting granulocyte-colony stimulating factor fusion protein for the prevention of chemotherapy-induced neutropenia: final results from the phase III clinical trial

Xiuchun Chen, Ruizhen Luo, Jingfen Wang, Baojiang Li, Zhiye Zhang, Yu Ren, Xujuan Wang, Jun Jia, Biyun Wang, Xinjian Jia, Xichun Hu, Xuchen Cao, Yi Tu, Honghuan Zhao, Jiazhuan Mei, Chaolong Zhu, Zhihua Li, Hongtao Li, Cuizhi Geng, Pei Wang, Liuzhong Yang, Lu Song, Guosheng Ren, Jian Chen, Xiaojia Wang, Jincheng Li, Caixia Liu, Yue-Yin Pan, Yiding Chen, Jing Sun, Chao Deng, Tao Sun, Yunhui Huang, Shuhai Wang, Ming‐De Huang, Shiyou Yu, Jingming Dong, Shao‐Qing Cai, Yumin Yao, Zhidong Pei
article en
1 citations

Abstract

The study findings confirm that 8MW0511 is not inferior to PEG-rhG-CSF in terms of efficacy and shows comparable safety profiles. Additionally, 8MW0511 has the potential to significantly decrease the duration of chemotherapy-induced neutropenia, along with a reduction in the occurrence of FN and severe neutropenia.

Breast Cancer ResearchVol. 27(1)
Qingdao University (CN), Hebei Medical University (CN), Shanghai Medical College of Fudan University (CN), Chongqing University (CN), Tianjin Medical University Cancer Institute and Hospital (CN), Yuhuangding Hospital (CN), Wuhan University (CN), Zhengzhou University (CN), Fudan University Shanghai Cancer Center (CN), Suizhou Central Hospital (CN), Huaian First People’s Hospital (CN), Zhejiang Cancer Hospital (CN), Cangzhou Central Hospital (CN), Fourth Hospital of Hebei Medical University (CN), People's Hospital of Cangzhou (CN), Deyang Stomatological Hospital (CN), First Affiliated Hospital of Xinxiang Medical University (CN), Suzhou Municipal Hospital (CN), Neijiang Normal University (CN), First Affiliated Hospital of Xi'an Jiaotong University (CN), Dongguan People’s Hospital (CN), Luoyang Central Hospital Affiliated to Zhengzhou University (CN), Chongqing Three Gorges Central Hospital (CN), Anhui Provincial Hospital (CN), The Affiliated Yongchuan Hospital of Chongqing Medical University (CN), First Affiliated Hospital of Henan University of Science and Technology (CN), Renmin Hospital of Wuhan University (CN), Henan Cancer Hospital (CN), Xian Yang Central Hospital (CN), First Affiliated Hospital of Bengbu Medical College (CN), Taian City Central Hospital (CN), Second Affiliated Hospital of Zhejiang University (CN), Liaocheng People's Hospital (CN), Liaoning Cancer Hospital & Institute (CN), Anyang Tumor Hospital (CN), Inner Mongolia Medical University (CN), Nanjing Medical University (CN), Jinzhou Medical University (CN), Chongqing Medical University (CN), China Medical University (CN)
Inner Mongolia Medical University, Henan University of Chinese Medicine, Chongqing University, Henan University of Science and Technology, Chongqing Medical University, Henan University, Zhejiang University, Wuhan University, Nanjing Medical University, China Medical University, University of Science and Technology of China, Qingdao University, Xinxiang Medical University, Hebei Medical University, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Renmin Hospital of Wuhan University
Openalex Percentile: Top 22%
Neutropenia and Cancer Infections
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.